3 years, 1 month ago

Serum Institute seeks DCGI nod for Covid vaccine Covovax

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India to manufacture Covid-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said. There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Serum Institute of India, is learnt to have said in the application sent to the DCGI. Read | Delta variant easily transmitted by vaccinated people in households: UK study "Approval of our Covovax and its availability will further strengthen India's capability to fight Covid-19 pandemic and ensure vaccine security in line with our prime minister's clarion call of Atmanirbhar Bharat," an official source quoted Singh as having said in the application. India has given emergency use permission to several Covid-19 vaccines, including Covishield, Covaxin of Bharat Biotech and Russian-made Sputnik V. Read | Centre permits export of 40 lakh doses of Covid-19 vaccine Sputnik Light manufactured in India to Russia Read | India proposes reciprocal vaccine certification mechanism to its partners: Foreign Secretary Shringla

Covid Vaccine Serum Institute Covovax India Sii Dcgi Nod vaccine seeks uk shoulder singh dcgi nod covid19 institute study sputnik covid covovax serum india sii

History of this topic

Serum Institute to manufacture Mpox vaccine by Danish maker Bavarian Nordic

Hindustan Times

Pune-based Serum Institute of India will be manufacturing Danish vaccine company Bavarian Nordic’s vaccine against mpox— MVA-BN— locally for the Indian market, according to latter’s statement issued on Monday on the license and manufacturing agreement signed between the two companies. “… Under the agreement, the companies will undertake a technology transfer of the current manufacturing process for MVA-BN® to SII …

7 months, 2 weeks ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

7 months, 2 weeks ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

7 months, 3 weeks ago

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Hindustan Times

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India. "@bharatbiotech announcement - …

7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

7 months, 4 weeks ago

India eyes to increase oral polio vaccine supply

Live Mint

New Delhi: The Centre is looking to increase the manufacturing capacity of oral polio vaccine, said Union Health and Family Welfare Secretary Apurva Chander. "An agreement has been signed under which Bharat Biotech will procure drug substances for manufacturing oral polio vaccines to be supplied within India and globally. With this partnership, the capacity of BBIL to manufacture Oral Polio …

10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

11 months, 4 weeks ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

1 year, 5 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

1 year, 8 months ago

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

Hindustan Times

Commenting on the recent spike in Covid cases countrywide, Serum Institute of India chief executive officer Adar Poonawalla on Saturday said that the current variant of the virus is not severe and five to six million doses of Covovax are available. We will also produce the same amount of Covishield doses in the next two to three months,” news agency …

1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

1 year, 8 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

1 year, 8 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

Hindustan Times

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

1 year, 8 months ago

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

Hindustan Times

Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry seeking the inclusion of its COVID-19 vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. The letter was written by Prakash Kumar Singh, Director, Serum Institute of India on March 27, they said. …

1 year, 9 months ago

Covid vaccine mission is a lesson for the world

Hindustan Times

When Covid-19 began in early 2020, most experts predicted India could face disastrous consequences. India’s response to the pandemic highlighted the underlying strengths of our scientific and technological prowess Not only did India succeed in protecting its population, but it also sent vaccines to other countries, thus proving to the world its capability of developing the first-ever DNA vaccine and …

1 year, 9 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

1 year, 10 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

1 year, 10 months ago

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

Hindustan Times

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's approval in November for restricted emergency use among adults as a heterologous booster dose. According to a statement issued …

1 year, 10 months ago

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched

Live Mint

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first made nasal vaccine against Covid-19 iNCOVACC. "Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the …

1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

1 year, 10 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

1 year, 11 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

1 year, 11 months ago

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla

Firstpost

Pune: Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati …

1 year, 11 months ago

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla

Hindustan Times

Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Adar Poonawalla, chief executive officer of Serum Institute of India Speaking to reporters on the sidelines of an event at the Bharati Vidyapeeth University here on Sunday, the SII …

1 year, 11 months ago

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla

Live Mint

As India braces for a possible rise in COVID-19 cases, a new vaccine is set to join the ranks as booster this month. Serum Institute of India's Covovax vaccine - which is effective against the Omicron strains - will get approval as a booster jab against COVID-19 in the next 10 to 15 days. All you need to know about …

1 year, 11 months ago

No second Covid-19 booster dose required: Report

Live Mint

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

1 year, 11 months ago

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Hindustan Times

Around 250 million Covid vaccines manufactured by two major Hyderabad-based units – Biological E and Bharat Biotech – are ready for dispatch in the market as soon as orders are received. Nearly 200 million Corbevax vaccine of Biological E and 50 million of Bharat Biotech's Covaxin are stockpiled at the moment. Read| Covid drills at hospitals; case count remains low …

1 year, 11 months ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

1 year, 11 months ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

1 year, 11 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

1 year, 11 months ago

Rs 800 at Pvt Hosps, Rs 325 at Govt Centres: India's 1st Needle-free Nasal Vax, Now Available as Booster

News 18

A single dose of Bharat Biotech’s intranasal vaccine iNCOVACC is now available on CoWin application for Rs 800, while Rs 325 has been fixed for purchase in government facilities. Provided that private hospitals are permitted to charge up to Rs 150 as an administrative charge for every dose of the Covid-19 vaccine, one dose of this vaccine developed on a …

2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

2 years ago

Indian Army issues advisory on Covid, asks defence personnel to take safety measures

India TV News

The Indian Army issued an advisory on Friday asking defence personnel to take up adequate measures to tackle COVID. The advisory asked them to take up measures such as the usage of face masks in closed or crowded places, practising hand sanitisation, and maintaining social distancing among others. Union Health Minister Dr Mansukh Mandaviya is set to hold a virtual …

2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

2 years ago

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla

The Hindu

Serum Institute of India CEO Adar Poonawalla on Tuesday expressed concern over reports of a rising COVID-19 graph in China but said there is no need to panic as the vaccination coverage in India is excellent. Mr. Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of …

2 years ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international Â“potential partnersÂ” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. Â“Since iNCOVACC has …

2 years, 1 month ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

2 years, 2 months ago

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k

Live Mint

India has witnessed a marginal decline in daily Covid-19 cases on Saturday with country recording 4,912 new infections in the past 24 hours, according to an update given by the Ministry of Health and Family Welfare. The country conducted 3,03,888 Covid tests in the last 24 hours, with the total number of tests conducted so far at 89.33 crore. The …

2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

2 years, 3 months ago

GAVI financing to allow for immediate funds for next pandemic

Live Mint

Global vaccine alliance GAVI has set up financial instruments that will allow the group to immediately access pledged donor funding if it needs to buy vaccines for future pandemics, Chief Executive Seth Berkley told Reuters. Berkley said that in 2020 and 2021, GAVI was limited in its ability to buy COVID-19 vaccines because even though donors had committed $2.4 billion, …

2 years, 3 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

2 years, 3 months ago

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use

News 18

Bharat Biotech has been given an emergency use authorisation by India’s drug regulator, the Drug Controller General of India, for its intranasal Covid-19 vaccine, Union Health Minister Dr Mansukh Mandaviya tweeted on Tuesday. Big Boost to India's Fight Against COVID-19!Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted …

2 years, 3 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

Discover Related

1 week ago

Mpox vaccine update: Serum Institute of India inks deal with Bavarian Nordic to produce the jab

Live Mint

Denmark's Bavarian Nordic has reached an agreement with the Serum Institute of India Pvt, to produce the Danish biotech firm’s Mpox vaccine. Bavarian Nordic confirmed in a statement on Monday that it will transfer technology to the Serum Institute, enabling the vaccine producer to supply shots for the Indian market, reported Bloomberg. Additionally, the agreement will allow the Serum Institute …

Global Reported Bloomberg Bavarian Nordic Serum Institute Bavarian Mpox Spread

1 week, 3 days ago

Mpox vaccine ready for clinical trial

China Daily

Test tubes about mpox virus are seen in this illustration taken on May 23, 2022. China's top drug regulator has recently approved clinical trials of a mpox vaccine developed by the domestic drugmaker Sinopharm, adding to a growing number of homegrown candidates in the pipeline, according to the company. The vaccine candidate from Sinopharm has proved safe and effective during …

China Mpox Clinical Trials Chinese Vaccine Clinical Trial Mpox Vaccine

1 week, 3 days ago

Mpox vaccine ready for clinical trial

China Daily

China Mpox Clinical Trials Chinese Vaccine Clinical Trial Mpox Vaccine

1 week, 4 days ago

Centre clears Rs 20,000 crore projects for Su-30 fighter jets, 100 K-9 howitzers

India TV News

In a major boost to the "Make in India" initiative in the defense sector, the Cabinet Committee on Security on Thursday approved two major projects valued at approximately Rs 20,000 crore. These include the procurement of 12 Su-30 MKI fighter jets for the Indian Air Force and 100 K-9 Vajra self-propelled howitzers for the Indian Army. 12 Su-30 MKI fighter …

Mki Crore Projects

2 weeks, 6 days ago

‘Quad-demic’ warning: Vaccine information for Covid, RSV, flu and norovirus

The Independent

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Dr Alexander Allen, consultant epidemiologist at UKHSA, said: “Flu is the cause of the rise …

Health Covid More Information Flu Nhs Health Check Rsv

3 weeks, 1 day ago

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

Live Mint

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. In a statement, Gilead said it has “an ongoing commitment to helping enable access to HIV prevention and treatment options where the need is the greatest.” Among the 120 countries eligible for generic version are 18 mostly African countries that …

Health World Prevention Latin America Mexico Countries Shot

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

Associated Press

Health World Prevention Latin America Mexico Countries Shot

3 weeks, 5 days ago

HPV vaccine makers eye growth overseas

China Daily

A medical staff member injects domestically produced bivalent HPV vaccine to a girl in Lianyungang, Jiangsu province, in May 2023. According to its latest financial report, in the first three quarters, Beijing-based Wantai Biopharm, a major HPV vaccine producer in China, reported revenue of 1.95 billion yuan, down 60.8 percent year-on-year, while net profit stood at 267 million yuan, a …

China Million Yuan Hpv Bivalent Vaccine Wantai

3 weeks, 5 days ago

HPV vaccine makers eye growth overseas

China Daily

China Million Yuan Vaccine Hpv Bivalent Wantai

3 weeks, 5 days ago

HPV vaccine makers eye growth overseas

China Daily

China Million Yuan Vaccine Hpv Bivalent Wantai

3 weeks, 5 days ago

HPV vaccine makers eye growth overseas

China Daily

A view of bivalent HPV vaccine of Wantai Biopharm in Chongqing on Nov 8. SUN KAIFANG/FOR CHINA DAILY In August, Shandong province's online procurement platform revealed that Walvax's bivalent HPV vaccine was priced at just 27.5 yuan per dose — about the same price as a cup of coffee. Health Guard's nine-valent HPV vaccine, covering both male and female indicators, …

Health China Male Vaccines Countries Chinese Vaccine

4 weeks ago

Wondering If It's Too Late To Get A COVID Vaccine Before Thanksgiving? Read This.

Huff Post

LOADING ERROR LOADING Thanksgiving week is here, and there’s a good chance your plans for the food-focused holiday are already in place. But if your plans to get the updated COVID-19 vaccine well before the holiday fell through, you may be wondering if it’s too late to get the shot before getting together with family and friends. Dr. David Wohl, …

Thanksgiving Vaccines Covid Cdc Shot Months Huffpost

1 month, 1 week ago

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin

Live Mint

MUMBAI, India & HYDERABAD, India – Business Wire India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part of this initiative, the National Institute of Allergy and Infectious Diseases, part of the …

Hyderabad Infectious Diseases Candidate Vaccine Mrna Niaid Project Nextgen

1 month, 1 week ago

First bivalent mRNA vaccine candidate against RSV goes under clinical trial

China Daily

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical trial in China on Wednesday, as an adult received a shot at a clinical research center of a major Shanghai hospital. "Official figures showed that RSV caused more than 80 percent of respiratory viral infection cases in infants and young children in …

Candidate Clinical Clinical Trial Rsv Vaccine Bivalent Mrna Innorna

1 month, 1 week ago

Health Talk | How eliminating polio has been one of the major successes of India's Universal Immunisation Programme

Hindustan Times

The World Immunisation Day is observed every year on November 10th. India is a classic example of what robust immunisation coverage against a disease can achieve in the form of the country's pulse polio programme, of which vaccination was a crucial part. India rolled out the Pulse Polio Immunization Programme on October 2 1994, and according to WHO India statement, …

Health India Disease Vaccines Immunisation Programme Diseases

1 month, 1 week ago

More irregularities found in Covid-19 fund use in Karnataka during BJP rule

India Today

Fresh details about the misappropriation of Covid-19 funds allotted for Karnataka have come to light. A staggering Rs 7.03 crore, earmarked for publicity, was allegedly redirected improperly, and an additional Rs 8.85 lakh was paid to an organisation called “Chukki Talkies” without clear justification. The health department could not produce records for Rs 5 crore in spending, reportedly allocated under …

Karnataka Commission Fund Bjp

1 month, 2 weeks ago

India to undertake mega study of covid-19 samples to help prepare for future pandemics

Live Mint

New Delhi: The Department of Biotechnology plans to undertake a study of thousands of samples and clinical material collected during covid-19 to help Indian scientists understand the susceptibility of individuals and changes in metabolic activity that will be useful in fighting future pandemics. The department will give the Indian SARS-CoV-2 Genomics Consortium, a consortium of 54 laboratories, the mandate to …

India Indian Official Covid Studies Dbt Future Pandemics

1 month, 3 weeks ago

Norovirus vaccine: What is it, when could it be available and will it be on the NHS?

The Independent

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} With norovirus …

Health Trial Norovirus Email Nhs Health Check Vaccine

1 month, 3 weeks ago

India's New Online Vaccine Portal: A Game Changer for Immunisation Coverage

Firstpost

U-WIN is an online platform in India that will revolutionise vaccine tracking and streamline the entire vaccine administration process. It will create a centralized digital record for vaccinations given to both pregnant women and children, making it easier to identify and support those who remain outside the vaccine net. The platform will also provide flexibility by allowing parents to self-register …

Law Technology Health Public Health

2 months ago

Global Pandemic Threat: 100 Days to Save Lives

Hindustan Times

A modelling study suggests that if a vaccine for SARS-CoV-2 had been developed within 100 days, an estimated 8.3 million deaths could have been averted globally. The study also estimated that productivity losses due to illness amounting to almost $1.4 trillion and $63 billion of hospitalisation costs would have been averted globally.

Government Science Law Health Talk

2 months ago

Covid vaccine: How to book a jab and who is eligible?

The Independent

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. UKHSA figures showed the admission rate for patients testing …

Health Email Nhs Health Check Vaccine Ukhsa Covid Vaccine

2 months, 3 weeks ago

Free COVID tests are back. Here's how to order a test to your home

The Independent

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Americans can once again order …

Test Tests Covid

3 months ago

Sea Observer Mission, Cancer Moonshot: Key Initiatives Reflect India's Strong Presence At Quad Leaders' Summit

News 18

India took centre stage at the Quad Leaders’ Summit attended by Prime Minister Narendra Modi on September 21, which was reflected in the official joint statement released by the member countries. India’s presence strongly resonated in some of the major announcements to come out of the meeting: Quad Cancer Moonshot, a groundbreaking partnership to address the challenges posed by cancer …

India Cancer Maritime Region Leaders Mission Crore

3 months ago

Rwanda begins vaccinations against mpox amid a call for more doses for Africa

The Independent

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

Africa Rwanda Vaccine Congo Doses Countries Kaseya

3 months ago

Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine

Associated Press

DAKAR, Senegal — The global vaccine alliance Gavi will buy 500,000 doses of mpox vaccine to battle outbreaks of the disease in African countries, the organization said on Wednesday. Since the beginning of the year, there have been over 25,000 confirmed mpox cases and 723 related deaths, the vast majority in Congo, and the World Health Organization declared it a …

Mpox Congo Doses Global Vaccine Gavi

3 months ago

Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine

The Independent

Mpox Congo Doses Global Vaccine Gavi

3 months, 1 week ago

What to know about the available Covid-19, flu and RSV vaccines

CNN

CNN — It’s that time of year when any cough or sniffle could be Covid-19, flu or RSV — but there are ways to fend them off. Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the …

Vaccines Cnn Covid Older Cdc Last Year Flu

3 months, 1 week ago

ICMR ties up with IIL to develop jab against Zika virus

Hindustan Times

The Indian Council of Medical Research has started work on a vaccine against the Zika virus, in collaboration with vaccine manufacturer Indian Immunologicals Limited, people familiar with the matter said. IIL has signed a memorandum of association with ICMR for the clinical development of the vaccine — the country’s first codon de-optimised live attenuated vaccine against Zika — and Phase …

India Trial Indian Vaccine Develop Clinical Icmr

3 months, 1 week ago

WHO grants first mpox vaccine approval to ramp up response to disease in Africa

Associated Press

GENEVA — The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important step toward fighting the disease in Africa. “This first of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in …

Africa Mpox Vaccine

3 months, 1 week ago

Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine

Hindustan Times

Hyderabad-based Bharat Biotech on Wednesday announced its collaboration with US-based Alopexx Inc for development and commercialisation of the latter’s broad-spectrum anti-microbial vaccine in India and other low-income countries, which experts feel could be a game-changer in tackling the growing anti-microbial resistance threat. This collaboration aligns with our mission to provide safe, affordable, and high-quality vaccines to combat infectious diseases globally,” …

Vaccines Resistance Vaccine Infections Antimicrobial Bharat Biotech

3 months, 1 week ago

Chinese mpox vaccine to undergo clinical trial

China Daily

China Daily| Updated :2024-09-11 The country's top drug regulator has cleared a mpox vaccine developed by Chinese drugmaker Sinopharm for clinical trial on Monday, which could be the nation's first experimental dose to battle the deadly disease, according to the company. The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to …

China Mpox Vaccine Clinical Trial

3 months, 2 weeks ago

Chinese mpox vaccine to undergo clinical trial

China Daily

The country's top drug regulator has cleared a mpox vaccine developed by Chinese drugmaker Sinopharm for clinical trial on Monday, which could be the nation's first experimental dose to battle the deadly disease, according to the company. The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to play an important role …

China Mpox Vaccine Clinical Trial

$The first 100,000 doses of mpox vaccine reach Congo. But it’s a fraction of what is needed$

3 months, 2 weeks ago

The first 100,000 doses of mpox vaccine reach Congo. But it’s a fraction of what is needed

The Hindu

The first batch of mpox vaccine arrived in Congo’s capital on Thursday, September 5, 2024, the country’s authorities said, three weeks after the World Health Organization declared mpox outbreaks in 12 African countries a global emergency. About 380,000 doses of mpox vaccines have been promised by Western partners such as the European Union and the United States, Dr. Jean Kaseya, …

Health Africa Nigeria Outbreak Congo Doses Mpox Vaccines

$The first 100,000 doses of mpox vaccine reach Congo. But it’s a fraction of what is needed$

3 months, 2 weeks ago

The first 100,000 doses of mpox vaccine reach Congo. But it’s a fraction of what is needed

Associated Press

KINSHASA, Congo — The first batch of mpox vaccine arrived in Congo’s capital on Thursday, the country’s authorities said, three weeks after the World Health Organization declared mpox outbreaks in 12 African countries a global emergency. The 100,000 doses of the MVA-BN vaccine, manufactured by the Danish company Bavarian Nordic, have been donated by the European Union through HERA, the …

Mpox Congo Mpox Vaccine

3 months, 2 weeks ago

For people without insurance, updated Covid-19 shots are no longer free of charge at pharmacies

CNN

CNN — The rollout of updated Covid-19 vaccines has begun in the United States, but for the first time, the shots will no longer be free of charge for people without insurance at their local pharmacy. Last year, as the shots transitioned to the commercial market, the US Centers for Disease Control and Prevention’s Bridge Access Program provided free Covid-19 …

Health Insurance Local Vaccines Cost State Cnn

3 months, 2 weeks ago

‘Faulty’ COVID vaccine behind recruitment drive deaths: Jharkhand CM Hemant Soren

The Hindu

Jharkhand Chief Minister and Jharkhand Mukti Morcha leader Hemant Soren on Wednesday alleged that “faulty” COVID-19 vaccine doses administered by the BJP-led Union government were responsible for 12 candidates losing their lives during physical tests for an excise constable recruitment drive in the State. The Chief Minister alleged that the BJP-led government had given “faulty vaccines”, which have had a …

State Bjp Soren Covid Vaccine Deaths Jharkhand

3 months, 2 weeks ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

Vaccines Covid Months Vaccine Bennett Booster Tga

3 months, 3 weeks ago

UNICEF issues emergency tender to secure mpox vaccines with Africa CDC, Gavi and WHO

The Hindu

The United Nations Children's Fund has issued an emergency tender to secure mpox vaccines for crisis-hit countries in collaboration with the Gavi vaccine alliance, Africa CDC and the World Health Organization, the organizations said in a joint statement on Saturday, August 31, 2024. Under the tender, UNICEF will set up conditional supply agreements with vaccine manufacturers, the statement said. Earlier …

Unicef Mpox Vaccine Cdc Gavi

3 months, 3 weeks ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

Public Health Vaccine Iil This Intranasal Vaccine Indian Immunologicals Ltd

3 months, 3 weeks ago

Top physicians come together in Delhi to discuss evolving STI threats

Hindustan Times

Physicians from the country and across the world have converged in the Capital to discuss the current scenario of HIV and sexually transmitted infections and disease management strategies, at the 48th National Conference of the Indian Association for the Study of Sexually Transmitted Diseases and AIDS. With a theme of ‘Emerging and Re-emerging STIs’, the scientific deliberations covered both the …

India Delhi Conference Sexual Hpv Cervical Cancer Sti

3 months, 3 weeks ago

The new COVID vaccine is out — but you might not want to rush to get it

Raw Story

The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans: Get the shot now, with the latest covid outbreak sweeping the country, or hold it in reserve for the winter wave? “Covid is still very transmissible, very new, and people congregate inside in air-conditioned rooms during the summer,” …

Health Summer Vaccines New York Cdc Fda Vaccine

3 months, 3 weeks ago

‘Most people are confused’: What to know about the latest Covid shot

Politico

Even the Democratic National Convention turned into a superspreader event. And despite the virus’ prevalence — and the persistent threat of long Covid — public health officials are contending with a myriad of obstacles as they try to boost the population’s defenses, including dwindling enthusiasm for the shots, lackluster testing and the end of a program meant to help the …

Health Covid Cdc Public Health Officials Vaccine Program

3 months, 3 weeks ago

Bharat Biotech unveils oral cholera vaccine developed in partnership with Hilleman Labs

The Hindu

Vaccine maker Bharat Biotech International Ltd on Tuesday launched Hillchol, a novel single-strain oral cholera vaccine it has developed under licence from Hilleman Laboratories. Bharat Biotech it has established large-scale manufacturing facilities in Hyderabad and Bhubaneswar with a capacity to produce up to 200 million doses of Hillchol, founder Krishna Ella and co-founder Suchitra Ella told media after the launch. …

India Hyderabad Bhubaneswar Bharat Vaccine Bharat Biotech Cholera

3 months, 3 weeks ago

Indian Immunologicals Ltd develops needle-free COVID-19 intranasal booster vaccine in collaboration with Australian university

The Hindu

Hyderabad-headquartered vaccine manufacturer Indian Immunologicals Ltd, in partnership with Griffith University, Australia has developed a needle-free intra-nasal booster vaccine against SARS-CoV-2, a press release from the company stated. According to the press release, codon de-optimisation involves decreasing the frequency of underrepresented codon pairs without changing the amino acid sequences. K. Anand Kumar, managing director, Indian Immunologicals Limited said as per …

India Vaccine

3 months, 3 weeks ago

Mpox: Drug regulator approves India's indigenous RT-PCR kit

Hindustan Times

The World Health Organisation has announced its second public health emergency of International concern due to Monkey Pox. Now, India has developed its own home-grown indigenous RT-PCR testing kit to fight against Mpox, which has been approved by Central Protection Drugs Standard Control Organisation. IMDX Monkeypox Detection RT-PCR Assay by Siemens Healthineers has received manufacturing approval from the Central Drugs …

India Mpox Pcr Kit Monkeypox Imdx Assay

3 months, 4 weeks ago

As COVID wave wallops California, new vaccines arrive this week. Will it be a turning point?

LA Times

New COVID-19 vaccines are expected to be available as soon as this week, a promising development amid California’s potent and enduring summer wave of the disease. “I have a tremendous empathy, having seen people struggle with long COVID in their 30s and 40s, people who you might think were otherwise low-risk,” Dr. Peter Marks, the FDA’s vaccine chief, said Friday. …

Winter Coronavirus Risk California Vaccines Marks Long Covid

4 months ago

Government announces more COVID-19 tests can be ordered through mail for no cost

Associated Press

WASHINGTON — On the heels of a summer wave of COVID-19 cases, Americans will be able to get free virus test kits mailed to their homes, starting in late September. U.S. households will be able to order up to four COVID-19 nasal swab tests when the federal program reopens, according to the website, COVIDtests.gov. The announcement also comes as the …

Tests

4 months ago

FDA approves updated COVID-19 vaccines; shots should be available in days

LA Times

With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses of the new COVID019 vaccine. U.S. regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter too. “We strongly encourage those who are eligible to consider receiving …

Virus Fda Vaccine Moderna Updated Shots Pfizer

4 months ago

The new COVID shot is now available. Here's what you need to know

NPR

The new COVID shot is now available. "But if we can prevent people from getting serious cases that end up in emergency rooms, hospitals or worse — dead — that’s what we’re trying to do with these vaccines.” Sponsor Message On average across all age groups, the two mRNA vaccines should cut the risk of having COVID-19 by 60% to …

Health Vaccines Marks Covid Shot Months Fda